{"content":"<li class=\"n-box-item date-title\" data-end=\"1492833599\" data-start=\"1492747200\" data-txt=\"Monday, December 23, 2019\">Friday, April 21, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3258806\" data-ts=\"1492816463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258806-eyegateminus-4_8-after-filing-for-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate -4.8% after filing for offering</a></h4><ul>   <li>Clinical-stage firm EyeGate Pharmaceuticals (<a href=\"http://seekingalpha.com/symbol/EYEG\" target=\"_blank\">EYEG</a> <font color='red'>-0.5%</font>) is <font color='red'>4.8% lower</font> in postmarket trade after <a href=\"https://seekingalpha.com/filing/3511226\" target=\"_blank\">filing an S-1 to offer shares</a>.</li>    <li>The company has registered initially for a maximum offering of $11.5M, with Wedbush PacGrow listed as underwriter.</li>    <li>It says it intends to use proceeds to support operations \"including for clinical trials, for working capital and for other general corporate purposes.\"</li>    <li>Shares are <font color='green'>up 28.2%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258806\" data-linked=\"EyeGate -4.8% after filing for offering\" data-tweet=\"$EYEG - EyeGate -4.8% after filing for offering https://seekingalpha.com/news/3258806-eyegateminus-4_8-after-filing-for-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3258806-eyegateminus-4_8-after-filing-for-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258805\" data-ts=\"1492816069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOMA\" target=\"_blank\">XOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258805-xomaminus-9_6-novo-nordisk-cancels-exclusive-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XOMA -9.6% as Novo Nordisk cancels exclusive deal</a></h4><ul>   <li>XOMA (<a href=\"http://seekingalpha.com/symbol/XOMA\" target=\"_blank\">XOMA</a> <font color='green'>+3.5%</font>) has slid in after-hours trade, <font color='red'>-9.6%</font>, after saying that Novo Nordisk (<a href=\"http://seekingalpha.com/symbol/NVO\" target=\"_blank\">NVO</a> <font color='red'>-1.4%</font>) has <a href=\"https://seekingalpha.com/filing/3511474\" target=\"_blank\">terminated its exclusive license deal</a> with the company, due to \"strategic and business reasons.\"</li>    <li>That termination is effective 90 days from yesterday.</li>    <li>XOMA lowered guidance on potential milestone payments (for the next 36 months) accordingly, to $40M from a previous $50M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258805\" data-linked=\"XOMA -9.6% as Novo Nordisk cancels exclusive deal\" data-tweet=\"$XOMA $XOMA $NVO - XOMA -9.6% as Novo Nordisk cancels exclusive deal https://seekingalpha.com/news/3258805-xomaminus-9_6-novo-nordisk-cancels-exclusive-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3258805-xomaminus-9_6-novo-nordisk-cancels-exclusive-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258802\" data-ts=\"1492809694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRWI\" target=\"_blank\">DRWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258802-dragonwave-still-failing-nasdaq-compliance-facing-delisting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DragonWave still failing Nasdaq compliance, facing delisting</a></h4><ul>   <li>DragonWave (<a href=\"http://seekingalpha.com/symbol/DRWI\" target=\"_blank\">DRWI</a> <font color='red'>-2%</font>) has heard from Nasdaq that it <a href=\"https://seekingalpha.com/pr/16806771-dragonwave-announces-receipt-nasdaq-staff-determination-company-request-hearing\" target=\"_blank\">hasn't regained compliance</a> with the exchange's minimum shareholders' equity requirement.</li>    <li>The company had been given until April 17 to maintain $2.5M in shareholders' equity but failed.</li>    <li>As a result, DragonWave was set to be delisted on May and will request a hearing to avoid that fate. Nasdaq's panel is empowered to grant up to 180 calendar days from yesterday to regain that compliance.</li>    <li>Shares are <font color='red'>off another 2%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258802\" data-linked=\"DragonWave still failing Nasdaq compliance, facing delisting\" data-tweet=\"$DRWI - DragonWave still failing Nasdaq compliance, facing delisting https://seekingalpha.com/news/3258802-dragonwave-still-failing-nasdaq-compliance-facing-delisting?source=tweet\" data-url=\"https://seekingalpha.com/news/3258802-dragonwave-still-failing-nasdaq-compliance-facing-delisting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258797\" data-ts=\"1492809097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258797-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/IJS' title='iShares S&P Small-Cap 600 Value ETF'>IJS</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/IWM' title='iShares Russell 2000 ETF'>IWM</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/IWC' title='iShares Micro-Cap ETF'>IWC</a> <font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a> <font color='green'>+2.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='red'>-10.0%</font>. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='red'>-7.3%</font>. <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a> <font color='red'>-6.9%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-5.9%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-5.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258797\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$IJS $IWM $IWC - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3258797-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258797-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258777\" data-ts=\"1492804471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258777-schlumberger-call-redeploying-gulf-assets-activating-idle-capacity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger call: Redeploying Gulf assets, activating idle capacity</a></h4><ul>   <li>Schlumberger (NYSE:<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a>) -- now <font color='red'>down 2.5%</font> after <a href=\"https://seekingalpha.com/news/3258694-schlumberger-minus-3-percent-revenue-miss-sluggish-international-outlook\" target=\"_blank\">missing on revenues</a> in earnings earlier today -- plans to redeploy assets from the Gulf of Mexico to more profitable use, execs said on the <a href=\"https://seekingalpha.com/article/4064240-schlumbergers-slb-ceo-paal-kibsgaard-q1-2017-results-earnings-call-transcript\" target=\"_blank\">company's earnings call</a>.</li>    <li>Demand for offshore services in the Gulf <a href=\"http://www.bizjournals.com/houston/news/2017/04/21/schlumberger-to-redeploy-assets-from-the-gulf-of.html\" target=\"_blank\">slid in the first quarter</a>, says Operations President Patrick Schorn, with pricing falling too far to turn a profit.</li>    <li>Meanwhile, strength in North America is prompting the company to mobilize idled assets. \"We've always said that as soon as we had a clear path to profitability, we would start activating our idled capacity,\" said CEO Paul Kibsgaard -- and so it will redeploy its entire idled hydraulic fracturing fleet by the end of the year, meaning new hiring.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258777\" data-linked=\"Schlumberger call: Redeploying Gulf assets, activating idle capacity\" data-tweet=\"$SLB - Schlumberger call: Redeploying Gulf assets, activating idle capacity https://seekingalpha.com/news/3258777-schlumberger-call-redeploying-gulf-assets-activating-idle-capacity?source=tweet\" data-url=\"https://seekingalpha.com/news/3258777-schlumberger-call-redeploying-gulf-assets-activating-idle-capacity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258772\" data-ts=\"1492802325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPC\" target=\"_blank\">PPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258772-pilgrims-prideplus-10-after-vertical-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pilgrim&#39;s Pride +10% after Vertical upgrades</a></h4><ul><li>Pilgrim's Pride (<a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='green'>+10.1%</font>)&nbsp;<font color='green'>jumps 10%</font>&nbsp;to reach its highest level of the year after Vertical Group boosts its rating to Buy from Neutral.</li><li>The firm thinks the outlook for pricing is favorable for the chicken seller this year and next.</li><li>While Pilgrim's Pride is already up 36% YTD, Vertical's price target of $30 gives shares another 13% to run.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258772\" data-linked=\"Pilgrim&#39;s Pride +10% after Vertical upgrades\" data-tweet=\"$PPC - Pilgrim&#39;s Pride +10% after Vertical upgrades https://seekingalpha.com/news/3258772-pilgrims-prideplus-10-after-vertical-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3258772-pilgrims-prideplus-10-after-vertical-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258771\" data-ts=\"1492801957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258771-ocwen-downgraded-s-and-p\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen downgraded at S&amp;P</a></h4><ul><li>Yesterday's new legal assault has S&amp;P cutting the credit rating on Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) to B- from B. Ratings could be cut further, says S&amp;P, as the allegations could potentially threaten the company's viability.</li><li>Ocwen has given up most of the early morning bounce, now&nbsp;<font color='green'>higher by 1.6%</font>.</li><li>Altisource Portfolio Solutions (<a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a> <font color='red'>-3.7%</font>), New Residential (<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a> <font color='green'>+0.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258771\" data-linked=\"Ocwen downgraded at S&amp;P\" data-tweet=\"$OCN $OCN $ASPS - Ocwen downgraded at S&amp;P https://seekingalpha.com/news/3258771-ocwen-downgraded-s-and-p?source=tweet\" data-url=\"https://seekingalpha.com/news/3258771-ocwen-downgraded-s-and-p\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258769\" data-ts=\"1492801214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258769-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> STV <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/INTT' title='inTest Corporation'>INTT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258769\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$STVVY $IPDN $DWCH - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3258769-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258769-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258767\" data-ts=\"1492801081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSYY\" target=\"_blank\">TOSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258767-nikkei-kkr-planning-joint-bid-for-toshiba-memory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nikkei: KKR planning joint bid for Toshiba Memory</a></h4><ul>   <li><font color='red'>Down as much as 6.7%</font> today in U.S. trading, Toshiba (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='red'>-3.5%</font>) is cutting losses after a <a href=\"http://asia.nikkei.com/Spotlight/Toshiba-in-Turmoil/KKR-public-private-fund-plan-bid-for-Toshiba-Memory\" target=\"_blank\">Nikkei report</a> suggests that KKR (<a href=\"http://seekingalpha.com/symbol/KKR\" target=\"_blank\">KKR</a> <font color='red'>-0.9%</font>) will team with Japan's Innovation Network Corp. for a joint offer for Toshiba's memory-chip unit.</li>    <li>Such a tender would put the KKR group in pole position, Nikkei suggests. The group would participate in the second bidding round for the NAND unit, set to happen in May.</li>    <li>Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='red'>-1.2%</font>) is still considered among the leaders and may join in as well, along with the Development Bank of Japan. Despite bids from WDC rivals that are reportedly as high as &yen;3T (about $27.5B), \"the amount offered isn't everything,\" Nikkei quotes a senior Toshiba exec as saying. (via Reuters)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258767\" data-linked=\"Nikkei: KKR planning joint bid for Toshiba Memory\" data-tweet=\"$TOSYY $TOSYY $KKR - Nikkei: KKR planning joint bid for Toshiba Memory https://seekingalpha.com/news/3258767-nikkei-kkr-planning-joint-bid-for-toshiba-memory?source=tweet\" data-url=\"https://seekingalpha.com/news/3258767-nikkei-kkr-planning-joint-bid-for-toshiba-memory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258765\" data-ts=\"1492799247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IHRTQ\" target=\"_blank\">IHRTQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258765-iheartmediaminus-3_1-bondholders-reportedly-uniting-to-block-exchange\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IHeartMedia -3.1% with bondholders reportedly uniting to block exchange</a></h4><ul>   <li>IHeartMedia (IHRT) is <font color='red'>off 3.1%</font> with trading picking up alongside news that a group of its lenders have come together to <a href=\"http://www.reuters.com/article/iheartmedia-restructuring-idUSL1N1HS2FJ\" target=\"_blank\">block its debt overhaul</a>, as Reuters reports.</li>    <li>That would start to choke off options for the struggling company aside from bankruptcy, as it works to address a debt pile amounting to $20B. The bondholders in question say they represent more than half of the term loan holders, enough to stop a debt swap.</li>    <li>The latest deadline for IHeartMedia's loan swap offer is later today; it's been postponed a couple of times.</li>    <li>Meanwhile, a filing from the company -- owner of iHeartRadio and Clear Channel Outdoor Holdings (<a href=\"http://seekingalpha.com/symbol/CCO\" target=\"_blank\">CCO</a> <font color='red'>-3.4%</font>) -- says that it expects to include a going-concern doubt in upcoming financials, due to continued negative cash flow and nearly $350M in debt coming due this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258765\" data-linked=\"IHeartMedia -3.1% with bondholders reportedly uniting to block exchange\" data-tweet=\"$IHRTQ $IHRT $CCO - IHeartMedia -3.1% with bondholders reportedly uniting to block exchange https://seekingalpha.com/news/3258765-iheartmediaminus-3_1-bondholders-reportedly-uniting-to-block-exchange?source=tweet\" data-url=\"https://seekingalpha.com/news/3258765-iheartmediaminus-3_1-bondholders-reportedly-uniting-to-block-exchange\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258758\" data-ts=\"1492796973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKY\" target=\"_blank\">RCKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258758-post-earnings-rip-for-rocky-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rip for Rocky Brands</a></h4><ul> <li>Rocky Brands (<a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+11.5%</font>) shoots higher after topping Q1 profit estimates. The company doubled revenue in its military segment to help give it some sales leverage. SG&amp;A expenses fell to 570 bps to 27.6% of sales during the quarter.</li> <li>The increase in lower-margin military sales did lead to a 160 bps drop in the company's gross margin rate to 31.3%.</li> <li>Shares of Rocky Brands are back over $12 for the first time since early February.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258758\" data-linked=\"Post-earnings rip for Rocky Brands\" data-tweet=\"$RCKY - Post-earnings rip for Rocky Brands https://seekingalpha.com/news/3258758-post-earnings-rip-for-rocky-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3258758-post-earnings-rip-for-rocky-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258755\" data-ts=\"1492796658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258755-interpublic-groupminus-2_1-international-results-drag-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group -2.1% as international results drag on revenues</a></h4><ul>   <li>Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) has <font color='red'>slipped 2.1%</font> in U.S. trading after <a href=\"https://seekingalpha.com/news/3258614-interpublic-group-companies-beats-0_02-misses-revenue\" target=\"_blank\">Q1 revenues</a> came up just short of expectations.</li>    <li>Revenue grew slightly overall in a seasonally small quarter, but was dragged by international results, where revenues fell 1.3% (up 2.2% on an organic basis).</li>    <li>But profits beat as net income available to stockholders nearly quadrupled, to $21.5M.</li>    <li>Revenue by geography: United States, $1.11B (up 1.9%); International, $642.1M (down 1.3%).</li>    <li>Cash and equivalents and marketable securities came to $778.1M as of March 31, vs. $1.1B at year-end 2016. Total debt was $1.92B.</li>    <li>The business is sound, says CEO Michael Roth. \"We therefore believe we are well positioned to achieve our full year targets of organic revenue in the 3% to 4% range, as well as to improve operating margin by an additional 50 basis points relative to 2016 levels.\"</li>    <li><a href=\"http://www.interpublic.com/news/pressreleases?release_id=2263590\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258755\" data-linked=\"Interpublic Group -2.1% as international results drag on revenues\" data-tweet=\"$IPG - Interpublic Group -2.1% as international results drag on revenues https://seekingalpha.com/news/3258755-interpublic-groupminus-2_1-international-results-drag-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3258755-interpublic-groupminus-2_1-international-results-drag-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258748\" data-ts=\"1492795167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258748-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='green'>+12%</font>.<a href='https://seekingalpha.com/symbol/CVCY' title='Central Valley Community Bancorp'>CVCY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LION' title='Fidelity Southern Corporation'>LION</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> WAC <font color='red'>-8%</font>. PBIB <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ENFC' title='Entegra Financial Corp'>ENFC</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258748\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$CARV $OPHC $CVCY - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3258748-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258748-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258736\" data-ts=\"1492793329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258736-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> STV <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping, Inc.'>DSX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CLW' title='Clearwater Paper Corporation'>CLW</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258736\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$STVVY $GLBS $CAI - Midday Gainers / Losers https://seekingalpha.com/news/3258736-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258736-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258732\" data-ts=\"1492791940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258732-proofpointplus-8_1-after-q1-beat-wows-analysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint +8.1% after Q1 beat wows analysts</a></h4><ul>   <li>Proofpoint (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) is <font color='green'>up 8.1%</font> today, rebounding from Thursday losses following a <a href=\"https://seekingalpha.com/news/3258549-proofpoint-rebounds-7_4-percent-beat-raised-guidance\" target=\"_blank\">beat-and-raise in its Q1</a> where it allayed worries about its sales force with solid growth in revenue and billings.</li>    <li>Bear arguments on the stock \"go up in smoke,\" writes RBC's Matthew Hedberg, pointing to relief of sales worries as well as free cash flow margins of 25% that increased confidence in holding that margin to 2020. He's got a price target of $92, implying 19.8% upside from today's higher price.</li>    <li>The company's \"executing flawlessly\" and displacing old brand names Symantec, McAfee, Cisco and Microsoft, says Piper Jaffray's Andrew Nowinski, who has a $90 price target and still considers the stock a top pick for this year.</li>    <li>A higher price target of $97 comes from Morgan Stanley. The shift to Office 365 is a material catalyst, notes Melissa Gorham, and the company has a solid pipeline of deals going.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258732\" data-linked=\"Proofpoint +8.1% after Q1 beat wows analysts\" data-tweet=\"$PFPT - Proofpoint +8.1% after Q1 beat wows analysts https://seekingalpha.com/news/3258732-proofpointplus-8_1-after-q1-beat-wows-analysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3258732-proofpointplus-8_1-after-q1-beat-wows-analysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258730\" data-ts=\"1492791340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258730-cabot-oil-gasminus-2_2-after-raymond-james-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabot Oil &amp; Gas -2.2% after Raymond James downgrade</a></h4><ul><li>Analyst John Freeman is still bullish on the name, but he now<a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/21/cabot-oil-gas-still-a-buy-just-not-a-strong-buy-says-raymond-james/?mod=BOL_hp_blog_stw\" target=\"_blank\"> rates it just Outperform</a> instead of Strong Buy. He also cuts his estimate of net asset value $27 fro $32. Today's decline has the stock at just under $24.</li><li>Among his reasons is Cabot's (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='red'>-2.2%</font>) recent outperformance and the idea of less NAV upside given lower natural gas price assumptions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258730\" data-linked=\"Cabot Oil &amp; Gas -2.2% after Raymond James downgrade\" data-tweet=\"$COG - Cabot Oil &amp; Gas -2.2% after Raymond James downgrade https://seekingalpha.com/news/3258730-cabot-oil-gasminus-2_2-after-raymond-james-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3258730-cabot-oil-gasminus-2_2-after-raymond-james-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258725\" data-ts=\"1492790496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258725-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/STS' title='Supreme Industries, Inc'>STS</a> <font color='green'>+6%</font>. SPU <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLW' title='Clearwater Paper Corporation'>CLW</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258725\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$RCKY $PPC $NAKD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3258725-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258725-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258722\" data-ts=\"1492790271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258722-onconova-prices-stock-offering-2_10-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova prices stock offering at $2.10; shares down 14%</a></h4><ul><li>Thinly traded nano cap Onconova (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-14.1%</font>) slumps on almost a 4x surge in volume in response to the <a href=\"https://seekingalpha.com/pr/16806387-onconova-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing </a>of its public offering of 2,476,190 shares of common stock at $2.10. Net proceeds will fund the development of rigosertib for higher-risk MDS. Closing date is April 26.</li><li>Yesterday's close was $2.49.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258722\" data-linked=\"Onconova prices stock offering at $2.10; shares down 14%\" data-tweet=\"$ONTX - Onconova prices stock offering at $2.10; shares down 14% https://seekingalpha.com/news/3258722-onconova-prices-stock-offering-2_10-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3258722-onconova-prices-stock-offering-2_10-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258719\" data-ts=\"1492789603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258719-immunomedics-off-13-on-no-asco-update-on-immuminus-132\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics off 13% on no ASCO update on IMMU-132</a></h4><ul><li>Jefferies analyst Matthew Andrews says that Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='red'>-12.9%</font>) confirmed that it will not present an update on top cancer candidate IMMU-132 at ASCO in June.</li><li>A Phase 1/2 study in epithelial cancers is recruiting patients. Separate Phase 2 and Phase 3 studies in triple-negative breast cancer are about to start.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3258719\" data-linked=\"Immunomedics off 13% on no ASCO update on IMMU-132\" data-tweet=\"$IMMU - Immunomedics off 13% on no ASCO update on IMMU-132 https://seekingalpha.com/news/3258719-immunomedics-off-13-on-no-asco-update-on-immuminus-132?source=tweet\" data-url=\"https://seekingalpha.com/news/3258719-immunomedics-off-13-on-no-asco-update-on-immuminus-132\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258717\" data-ts=\"1492789299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258717-oil-tumbles-below-50-dragging-down-energy-names\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil tumbles below $50, dragging down energy names</a></h4><ul><li>A&nbsp;<font color='red'>2.3% drop</font>&nbsp;today has crude oil below $50 per barrel for the first time in a month, now at $49.55. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a><font color='red'> -1.85%</font></li><li>Alongside, the energy sector's (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-0.7%</font>) loss is outpacing just a&nbsp;<font color='red'>0.1% decline</font>&nbsp;in the S&amp;P 500.</li><li>There's also earnings, and Schlumberger is&nbsp;<font color='red'>off 3.15%</font>&nbsp;after missing on revenues <a href=\"https://seekingalpha.com/news/3258694-schlumberger-minus-3-percent-revenue-miss-sluggish-international-outlook\" target=\"_blank\">and offering</a> a somewhat dour outlook. The SPDR Oil &amp; Gas Services ETF (<a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a> <font color='red'>-2.2%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='PowerShares Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Guggenheim S&P Equal Weight Energy ETF'>RYE</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258717\" data-linked=\"Oil tumbles below $50, dragging down energy names\" data-tweet=\"$USO $XLE $XES - Oil tumbles below $50, dragging down energy names https://seekingalpha.com/news/3258717-oil-tumbles-below-50-dragging-down-energy-names?source=tweet\" data-url=\"https://seekingalpha.com/news/3258717-oil-tumbles-below-50-dragging-down-energy-names\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258708\" data-ts=\"1492787051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUN\" target=\"_blank\">FUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258708-fun-stuff-for-cedar-fair-new-all-time-high-struck\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fun stuff for Cedar Fair as new all-time high struck</a></h4><ul> <li>Stifel Nicolaus initiates coverage on Cedar Fair (<a href='https://seekingalpha.com/symbol/FUN' title='Cedar Fair, L.P.'>FUN</a> <font color='green'>+1.7%</font>) with a <a href=\"https://twitter.com/Briefingcom/status/855379861883338753\" target=\"_blank\">Buy rating</a> and $78 price target.</li> <li>The investment firm thinks the company will continue to increase EBITDA as it utilizes new land it acquired.</li> <li>Shares of Cedar Fair crossed $70 for the first time ever today, topping out at $70.41 within the last hour. Even with the extended rally for FUN, the dividend yield is at 4.86% for new investors.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258708\" data-linked=\"Fun stuff for Cedar Fair as new all-time high struck\" data-tweet=\"$FUN - Fun stuff for Cedar Fair as new all-time high struck https://seekingalpha.com/news/3258708-fun-stuff-for-cedar-fair-new-all-time-high-struck?source=tweet\" data-url=\"https://seekingalpha.com/news/3258708-fun-stuff-for-cedar-fair-new-all-time-high-struck\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258680\" data-ts=\"1492786848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258680-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SSKN' title='STRATA Skin Sciences, Inc'>SSKN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CASC' title='Cascadian Therapeutics, Inc'>CASC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-14%</font>. APRI <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258680\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PTX-OLD $SSKN $AKTX - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3258680-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3258680-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258696\" data-ts=\"1492785746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258696-hawaiian-holdings-jets-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Holdings jets higher</a></h4><ul> <li>Buckingham Research <a href=\"https://twitter.com/BuckResearch/status/855383165917122561\" target=\"_blank\">upgrades</a> Hawaiian Holdings (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color='green'>+6.2%</font>) to a Buy rating from Neutral.</li> <li>The firm increases its price target to $63 from $55, saying the company found its \"sweet spot\" with strategy.</li> <li>Shares of Hawaiian Holdings are<font color='green'> up 6.26%</font> on the day and are back over $55 for the first time in almost three months.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258696\" data-linked=\"Hawaiian Holdings jets higher\" data-tweet=\"$HA - Hawaiian Holdings jets higher https://seekingalpha.com/news/3258696-hawaiian-holdings-jets-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3258696-hawaiian-holdings-jets-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258694\" data-ts=\"1492785327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258694-schlumbergerminus-3-after-revenue-miss-sluggish-international-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger -3% after revenue miss, sluggish international outlook</a></h4><ul><li>Q1 adjusted income of $347M or $0.25 per share was inline with estimates, and down from $501M and $0.40 one year ago. Revenue of $6.89B was up 6% Y/Y, and shy of estimates by $100M.</li><li>Revenue fell 7% sequentially in international markets, and - speaking on the earnings call (IBD's <a href=\"https://twitter.com/IBD_GRich\" target=\"_blank\">Gillian Rich listening in</a>) - management says 2017 looks like another challenging year. While Latin America has bottomed, Asia is showing no signs of recovery.</li><li>North America is looking better, with the company expecting a 50% increase in investment levels this year.</li><li>International accounts for about 75% of company revenue.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258604-schlumberger-eps-line-misses-revenue\" target=\"_blank\">Schlumberger EPS in-line, misses on revenue</a> (April 21)</li><li><a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a><font color='red'> -3%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3258694\" data-linked=\"Schlumberger -3% after revenue miss, sluggish international outlook\" data-tweet=\"$SLB - Schlumberger -3% after revenue miss, sluggish international outlook https://seekingalpha.com/news/3258694-schlumbergerminus-3-after-revenue-miss-sluggish-international-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3258694-schlumbergerminus-3-after-revenue-miss-sluggish-international-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258693\" data-ts=\"1492785279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258693-reuters-intelsat-oneweb-debt-exchange-to-get-several-weeks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Intelsat/OneWeb debt exchange to get several weeks more</a></h4><ul>   <li>Working to keep a merger with OneWeb alive and satisfy holdout bondholders, Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color='red'>-2.1%</font>) is planning to <a href=\"http://www.reuters.com/article/us-intlsat-m-a-oneweb-idUSKBN17M2YT?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202017-04-21&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">extend a deadline on its debt exchange</a> by several weeks, Reuters reports.</li>    <li>A deadline from last night will go out to at least mid-May, the report says.</li>    <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='green'>+0.2%</font>) <a href=\"https://seekingalpha.com/news/3247052-intelsat-oneweb-combine\" target=\"_blank\">moved to merge OneWeb</a> with Intelsat in February in a deal contingent on bondholder approval that would help cut $3.6B from Intelsat's $15B in debt.</li>    <li>But some of the debt is trading above the deal's exchange price, and SoftBank may be reluctant to sweeten that deal.</li>    <li>Holders of at least 85% of the face value of each series need to agree to the exchange to consummate the deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258693\" data-linked=\"Reuters: Intelsat/OneWeb debt exchange to get several weeks more\" data-tweet=\"$I $I $SFTBY - Reuters: Intelsat/OneWeb debt exchange to get several weeks more https://seekingalpha.com/news/3258693-reuters-intelsat-oneweb-debt-exchange-to-get-several-weeks?source=tweet\" data-url=\"https://seekingalpha.com/news/3258693-reuters-intelsat-oneweb-debt-exchange-to-get-several-weeks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258692\" data-ts=\"1492785265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258692-analysts-dish-out-good-bad-and-ugly-on-mattel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts dish out the good, the bad and the ugly on Mattel</a></h4><ul>     <li>Analysts agree that Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-10.4%</font>)&nbsp;turned in a painful post-holiday quarter, but differ on how investors should view the toy stock.</li>     <li>BMO Capital advises long-term investors to buy Mattel on the weakness with the new CEO steering the company in the right direction. On the recent quarter, analyst Gerrick Johnson has an explanation. \"In the toy industry, the first quarter is often called the fifth quarter, because it is where problems from the fourth quarter are often cleaned up -- this is precisely what we see happening with Mattel's business,\" he writes.</li>     <li>Goldman Sachs and SunTrust both cite execution risk in dropping their price target on Mattel to $25 and maintaining a Neutral/Hold ratings.</li>     <li>Today's note from Stifel may give dividend investors something to consider. \"While we think performance will improve beginning in 2Q with the theatrical release of 'Cars 3' driving growth, our confidence around sustaining the dividend continues to wane, which could serve as an overhang for the shares, at least near-term,\" warns analyst Drew Crum.</li>     <li>MKM Partners: \"Given the missteps seen in four of the last five years, we are skeptical about the current turnaround.\"</li>     <li>Sources: Bloomberg and <a href=\"http://www.cnbc.com/2017/04/21/mattels-shares-sink-as-the-street-loses-confidence-in-its-turnaround.html\" target=\"_blank\">CNBC</a>, <a href=\"https://www.thestreet.com/story/14095753/1/mattel-gets-thrashed-as-sales-of-barbie-dolls-fall-off-a-cliff.html\" target=\"_blank\">TheStreet</a>.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3258457-mattel-misses-0_15-misses-revenue\" target=\"_blank\">Mattel misses by $0.15, misses on revenue</a> (April 20)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3258479-inventory-overhang-whacks-bottom-line-mattel\" target=\"_blank\">Inventory overhang whacks bottom line at Mattel</a> (April 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258692\" data-linked=\"Analysts dish out the good, the bad and the ugly on Mattel\" data-tweet=\"$MAT - Analysts dish out the good, the bad and the ugly on Mattel https://seekingalpha.com/news/3258692-analysts-dish-out-good-bad-and-ugly-on-mattel?source=tweet\" data-url=\"https://seekingalpha.com/news/3258692-analysts-dish-out-good-bad-and-ugly-on-mattel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258687\" data-ts=\"1492783870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAI\" target=\"_blank\">CAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258687-cai-international-skyrockets-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CAI International skyrockets to 52-week high</a></h4><ul> <li>A huge profit beat sends shares of CAI International (NYSE:<a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a>) flying in early trading.</li> <li>The company reported an average container utilization rate in <a href=\"https://seekingalpha.com/pr/16805655-cai-international-inc-reports-results-first-quarter-2017\" target=\"_blank\">Q1</a> of 95.7%, up 140 bps Y/Y. The railcar utilization rate fell 80 bps to 92.7% during the quarter.</li> <li>\"We have been able to increase prices on the sale of used containers and expect that in the second quarter of this year we are likely to report a gain on sale, compared to the losses we have incurred in recent quarters,\" noted CEO Victor Garcia.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258436-cai-international-beats-0_14-beats-revenue\" target=\"_blank\">CAI International beats by $0.14, beats on revenue</a> (April 20)</li>  <li>Shares of CAI are <font color='green'>up 23.03%</font> to $19.07 and carved out a 52-week high of $19.37 earlier.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258687\" data-linked=\"CAI International skyrockets to 52-week high\" data-tweet=\"$CAI - CAI International skyrockets to 52-week high https://seekingalpha.com/news/3258687-cai-international-skyrockets-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3258687-cai-international-skyrockets-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258675\" data-ts=\"1492781879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258675-on-kansas-city-southerns-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Kansas City Southern&#39;s Q1</a></h4><ul><li>Kansas City Southern (<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a> <font color='red'>-1.7%</font>)&nbsp;reports carload volume rose 6% to 540.9K in <a href=\"https://seekingalpha.com/pr/16806229-kansas-city-southern-reports-record-first-quarter-revenues-carloads-operating-income\" target=\"_blank\">Q1</a>.</li><li>Revenue by segment: Chemical &amp; Petroleum: $126.5M (+8%);&nbsp;Industrial &amp; Consumer Products: $140.1M (-1%);&nbsp;Agriculture &amp; Minerals: $116.3M (+6%); Energy: $69M (+64%); Intermodal: $83.5M (-2%); Automotive: $51.3M (+25%), Other: $22.8M (-12%).</li><li>Revenue per carload/unit grew 4% to $1,085.</li><li>Operating margin rate improved 120 bps to 34.6%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258675\" data-linked=\"More on Kansas City Southern&#39;s Q1\" data-tweet=\"$KSU - More on Kansas City Southern&#39;s Q1 https://seekingalpha.com/news/3258675-on-kansas-city-southerns-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258675-on-kansas-city-southerns-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258672\" data-ts=\"1492781017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258672-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='red'>-33%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16805999-xbiotech-announces-outcome-ema-s-oral-explanation-meeting\" target=\"_blank\">announcing</a> outcome of European Medicines Agency's oral explanation meeting.</li><li><a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16805671-adamis-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcing</a> equity offering.</li><li><a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16806026-onconova-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcing</a> public stock offering.</li><li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-7%</font>.</li><li>APRI <font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16806103-apricus-biosciences-announces-pricing-7_0-million-public-offering\" target=\"_blank\">pricing</a> equity offering.</li><li><a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-5%</font>&nbsp;ahead of <a href=\"https://seekingalpha.com/news/3258648-aevi-genomic-present-data-today-failed-saga-study-shares-ease-9-percent-premarket\" target=\"_blank\">presentation</a> at the World Congress on results from the SAGA study.</li><li><a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3258457-mattel-misses-0_15-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258672\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$XBIT $ADMP $ONTX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3258672-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3258672-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258670\" data-ts=\"1492780629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258670-aurinias-voclosporin-meets-all-48-week-endpoints-in-mid-stage-ln-study-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia&#39;s voclosporin meets all 48-week endpoints in mid-stage LN study; shares ahead 5% premarket</a></h4><ul><li>Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16805903-aurinia-releases-additional-48-week-data-aura-lv-study-late-breaking-session-national-kidney\" target=\"_blank\">announcement </a>of positive 48-week data from the Phase 2b AURA-LV study assessing voclosporin for the treatment of lupus nephritis. The results are being presented at the National Kidney Foundation 2017 Spring Clinical Meetings in Orlando, FL.</li><li>The complete and partial remission endpoints were met in additional to all pre-specified secondary endpoints.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256128-aurinias-truncated-late-stage-development-plan-voclosporin-propels-shares-6-percent-premarket\" target=\"_blank\">Aurinia's truncated late-stage development plan for voclosporin propels shares 6% premarket</a> (April 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258670\" data-linked=\"Aurinia&#39;s voclosporin meets all 48-week endpoints in mid-stage LN study; shares ahead 5% premarket\" data-tweet=\"$AUPH - Aurinia&#39;s voclosporin meets all 48-week endpoints in mid-stage LN study; shares ahead 5% premarket https://seekingalpha.com/news/3258670-aurinias-voclosporin-meets-all-48-week-endpoints-in-mid-stage-ln-study-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3258670-aurinias-voclosporin-meets-all-48-week-endpoints-in-mid-stage-ln-study-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258669\" data-ts=\"1492780351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258669-ocwen-upgraded-compass-point-shares-higher-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen upgraded at Compass Point; shares higher by 13% premarket</a></h4><ul><li>Fred Small at Compass Point has been a notable bear on Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) in the past, so his upgrade to Buy this morning is at least somewhat notable. Shares are&nbsp;<font color='green'>higher by 13%</font>&nbsp;in active premarket action, but the move is barely a blip compared to yesterday's&nbsp;<font color='red'>53% washout</font>.</li><li>Wedbush's Hencry Coffey says Nationstar Mortgage (NYSE:<a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a>) could be a beneficiary of the latest Ocwen issues, maybe taking over the servicing Ocwen currently handles for New Residential, or possibly picking up business from Walter Investment (WAC) or <a href='https://seekingalpha.com/symbol/PHH' title='PHH Corporation'>PHH</a>.</li><li>Altisource Portfolio Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a>)&nbsp;<font color='green'>+7.3%</font>; Altisource Residential (NYSE:<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a>)&nbsp;<font color='green'>+2.4%</font></li><li>New Residential (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>)&nbsp;<font color='green'>+2.6%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3258617-ocwen-takes-issue-state-regulators\" target=\"_blank\">Ocwen takes issue with state regulators</a> (April 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258669\" data-linked=\"Ocwen upgraded at Compass Point; shares higher by 13% premarket\" data-tweet=\"$OCN $OCN $NSM - Ocwen upgraded at Compass Point; shares higher by 13% premarket https://seekingalpha.com/news/3258669-ocwen-upgraded-compass-point-shares-higher-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258669-ocwen-upgraded-compass-point-shares-higher-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258667\" data-ts=\"1492780350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258667-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li>STV <font color='green'>+44%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16806269-china-digital-tv-declares-special-cash-dividend-shareholders\" target=\"_blank\">declaring</a> special cash dividend to shareholders.</li><li><a href='https://seekingalpha.com/symbol/INUV' title='Inuvo, Inc'>INUV</a> <font color='green'>+28%.</font></li><li><a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+16%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16806112-ocwen-disputes-allegations-raised-state-regulators-will-continue-work-cooperatively-achieve\" target=\"_blank\">strongly</a> disputing the key allegations raised by the State Regulators and will continue to work cooperatively to achieve an acceptable resolution.</li><li><a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16805903-aurinia-releases-additional-48-week-data-aura-lv-study-late-breaking-session-national-kidney\" target=\"_blank\">announcing</a> additional 48-week results from its global Phase IIb AURA-LV study in lupus nephritis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258667\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$STVVY $INUV $OCN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3258667-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3258667-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258668\" data-ts=\"1492780338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258668-ohio-ag-probes-visa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ohio AG probes Visa</a></h4><ul> <li>The State of Ohio Office of the Attorney General issues a civil investigative demand against Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) relating to debit cards, debit card transaction routing procedures and cardholder verification methods.</li> <li>The company says it's cooperating with the investigation.</li> <li>The disclosure was made as part of Visa's <a href=\"https://seekingalpha.com/filing/3510288\" target=\"_blank\">10-Q filing</a> with the SEC.</li> <li>Shares of Visa are <font color='green'>up 2.24%</font> premarket after yesterday's <a href=\"https://seekingalpha.com/news/3258466-visa-higher-earnings-5b-buyback-plan\" target=\"_blank\">earnings beat</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258668\" data-linked=\"Ohio AG probes Visa\" data-tweet=\"$V - Ohio AG probes Visa https://seekingalpha.com/news/3258668-ohio-ag-probes-visa?source=tweet\" data-url=\"https://seekingalpha.com/news/3258668-ohio-ag-probes-visa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258660\" data-ts=\"1492779919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRA\" target=\"_blank\">ATRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258660-atara-bio-to-collaborate-merck-on-ata129-keytruda-combo-in-npc-shares-up-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atara Bio to collaborate with Merck on ATA129-Keytruda combo in NPC; shares up 11% premarket</a></h4><ul><li>Thinly traded micro cap Atara Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>) is up&nbsp;<font color='green'>11%&nbsp;</font>premarket, albeit on only 559 shares, in response to its <a href=\"https://seekingalpha.com/pr/16806209-atara-bio-announces-collaboration-merck-evaluate-keytruda-pembrolizumab-combination-ata129\" target=\"_blank\">announcement</a> of a clinical trial collaboration with Merck evaluating the combination of its allogeneic Epstein-Barr virus &#40;EBV&#41;-specific cytotoxic T lymphocytes (ATA129) and Keytruda (pembrolizumab) in patients with platinum-resistant or recurrent EBV-associated nasopharyngeal carcinoma &#40;NPC&#41;.</li><li>An Atara-sponsored Phase 1/2 study should be initiated next year. Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258660\" data-linked=\"Atara Bio to collaborate with Merck on ATA129-Keytruda combo in NPC; shares up 11% premarket\" data-tweet=\"$ATRA - Atara Bio to collaborate with Merck on ATA129-Keytruda combo in NPC; shares up 11% premarket https://seekingalpha.com/news/3258660-atara-bio-to-collaborate-merck-on-ata129-keytruda-combo-in-npc-shares-up-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258660-atara-bio-to-collaborate-merck-on-ata129-keytruda-combo-in-npc-shares-up-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258662\" data-ts=\"1492779639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPY\" target=\"_blank\">BPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258662-brookfield-property-boosts-terms-for-brookfield-canada-office-properties\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookfield Property boosts terms for Brookfield Canada Office Properties</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16805943-brookfield-canada-office-properties-enters-definitive-agreement-brookfield-property-partners\" target=\"_blank\">The two have agreed</a> on C$32.50 per share for the 17% interest that Brookfield Property Partners (NYSE:<a href='https://seekingalpha.com/symbol/BPY' title='Brookfield Property Partners L.P.'>BPY</a>) currently doesn't own. That's $2.40 per share more than BPY's original proposal in January, and&nbsp;<font color='green'>2.8% higher</font>&nbsp;than BOX's close in Toronto last night.</li><li>BOX trades on the NYSE as well under <a href='https://seekingalpha.com/symbol/BOXC' title='Brookfield Canada Office Properties'>BOXC</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3236721-brookfield-canada-plus-19-percent-analysts-see-better-offer-coming\" target=\"_blank\">Brookfield Canada +19%; analysts see better offer coming</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258662\" data-linked=\"Brookfield Property boosts terms for Brookfield Canada Office Properties\" data-tweet=\"$BPY $BPY $BOXC - Brookfield Property boosts terms for Brookfield Canada Office Properties https://seekingalpha.com/news/3258662-brookfield-property-boosts-terms-for-brookfield-canada-office-properties?source=tweet\" data-url=\"https://seekingalpha.com/news/3258662-brookfield-property-boosts-terms-for-brookfield-canada-office-properties\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258656\" data-ts=\"1492778911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIT\" target=\"_blank\">XBIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258656-xbiotech-gets-thumbs-down-on-crc-candidate-in-pre-opinion-meeting-ema-advisory-committee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XBiotech gets thumbs down on CRC candidate in pre-opinion meeting with EMA advisory committee; shares plummet 33% premarket</a></h4><ul><li>Thinly traded micro cap XBiotech (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a>) is down&nbsp;<font color='red'>33%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16805999-xbiotech-announces-outcome-ema-s-oral-explanation-meeting\" target=\"_blank\">announcement </a>of a negative outcome from its meeting with members of the European Medicines Agency's advisory committee regarding its Marketing Authorization Application &#40;MAA&#41; seeking approval of its candidate antibody to treat colorectal cancer.</li><li>In a meeting to discuss the Day 180 List of Outstanding Issues, members of the advisory committee CHMP rendered a \"negative trend\" vote which means that a positive opinion from its formal review of the MAA is unlikely. The key stumbling block appeared to be clinical relevance.</li><li>CEO John Simard says, &ldquo;We are disappointed by the outcome of the meeting. We believe that the data speak in a clear and resounding voice to clinical relevance of a new antibody therapy in advanced colorectal cancer. We believe that findings from our Phase III study show that we have developed an important endpoint and methodology to evaluate anti-cancer therapy in advanced stage disease and that our monoclonal antibody represents a breakthrough treatment in patients with advanced colorectal cancer. The EMA marketing authorization application procedure enables the appeal of negative decisions from the oral explanation. We may seek access to this process at the appropriate time.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3258656\" data-linked=\"XBiotech gets thumbs down on CRC candidate in pre-opinion meeting with EMA advisory committee; shares plummet 33% premarket\" data-tweet=\"$XBIT - XBiotech gets thumbs down on CRC candidate in pre-opinion meeting with EMA advisory committee; shares plummet 33% premarket https://seekingalpha.com/news/3258656-xbiotech-gets-thumbs-down-on-crc-candidate-in-pre-opinion-meeting-ema-advisory-committee?source=tweet\" data-url=\"https://seekingalpha.com/news/3258656-xbiotech-gets-thumbs-down-on-crc-candidate-in-pre-opinion-meeting-ema-advisory-committee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258655\" data-ts=\"1492778461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258655-hasbro-stung-soft-mattel-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro stung by soft Mattel results</a></h4><ul> <li>Shares of Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) trade lower after Mattel cited a \"retail inventory overhang\" as it sputtered out of the holiday period.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3258457-mattel-misses-0_15-misses-revenue\" target=\"_blank\">Mattel misses by $0.15, misses on revenue</a> (April 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258479-inventory-overhang-whacks-bottom-line-mattel\" target=\"_blank\">Inventory overhang whacks bottom line at Mattel</a> (April 20)</li> <li>HAS <font color='red'>-2.10%</font> premarket to $93.99 vs. a 52-week trading range of $76.14 to $101.18.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258655\" data-linked=\"Hasbro stung by soft Mattel results\" data-tweet=\"$HAS - Hasbro stung by soft Mattel results https://seekingalpha.com/news/3258655-hasbro-stung-soft-mattel-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3258655-hasbro-stung-soft-mattel-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258648\" data-ts=\"1492777455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMX\" target=\"_blank\">GNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258648-aevi-genomic-to-present-data-today-from-failed-saga-study-shares-ease-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aevi Genomic to present data today from failed SAGA study; shares ease 9% premarket</a></h4><ul><li>Aevi Genomic Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a>) is down&nbsp;<font color='red'>9%</font>&nbsp;premarket on light volume ahead of a presentation today at the World Congress on ADHD on results from the SAGA study assessing lead product candidate AEVI-001. Shares plummeted last month after the company announced it failed to beat placebo in adolescents with mGluR mutation-positive ADHD.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252211-aevi-genomics-lead-product-candidate-flunks-adhd-study-shares-plummet-56-percent\" target=\"_blank\">Aevi Genomic's lead product candidate flunks ADHD study; shares plummet 56%</a> (March 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258648\" data-linked=\"Aevi Genomic to present data today from failed SAGA study; shares ease 9% premarket\" data-tweet=\"$GNMX - Aevi Genomic to present data today from failed SAGA study; shares ease 9% premarket https://seekingalpha.com/news/3258648-aevi-genomic-to-present-data-today-from-failed-saga-study-shares-ease-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258648-aevi-genomic-to-present-data-today-from-failed-saga-study-shares-ease-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258643\" data-ts=\"1492776867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258643-on-gentexs-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Gentex&#39;s Q1</a></h4><ul>     <li>Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>)&nbsp;reports Automotive net sales increased 13% to $445.6M in <a href=\"https://seekingalpha.com/pr/16806214-gentex-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1</a>, due to 12% rise in auto-dimming mirror unit shipments .</li>     <li>Total auto-dimming mirror units +1092 Y/Y to 9,919.</li><li>Gross margin rate fell 30 bps to 38.8%&nbsp;due to annual customer price reductions.</li>          <li>Operating margin rate down 20 bps to 29.6%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258643\" data-linked=\"More on Gentex&#39;s Q1\" data-tweet=\"$GNTX - More on Gentex&#39;s Q1 https://seekingalpha.com/news/3258643-on-gentexs-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258643-on-gentexs-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258641\" data-ts=\"1492776180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258641-kansas-city-southern-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kansas City Southern beats by $0.01, beats on revenue</a></h4><ul><li>Kansas City Southern (NYSE:<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a>): Q1 EPS of $1.17 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $609.5M (+8.3% Y/Y) <font color='green'>beats by $10.19M</font>.</li><li>Shares <font color='green'>+1.58%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16806229-kansas-city-southern-reports-record-first-quarter-revenues-carloads-operating-income'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258641\" data-linked=\"Kansas City Southern beats by $0.01, beats on revenue\" data-tweet=\"$KSU - Kansas City Southern beats by $0.01, beats on revenue https://seekingalpha.com/news/3258641-kansas-city-southern-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258641-kansas-city-southern-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258635\" data-ts=\"1492775913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258635-bmo-spots-value-in-fortinet-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO spots value in Fortinet; shares up 1% premarket</a></h4><ul><li>An attractive valuation amid coming market share gains make for a good combination, and BMO analyst Keith Bachman upgrades to Outperform from Market Perform. His new price target of $46 is based on an enterprise value/free cash flow multiple of 16x-17x vs. an average of 18.6x over the past three years.</li><li><a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>&nbsp;<font color='green'>+1%</font>&nbsp;premarket to $38.89.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258635\" data-linked=\"BMO spots value in Fortinet; shares up 1% premarket\" data-tweet=\"$FTNT - BMO spots value in Fortinet; shares up 1% premarket https://seekingalpha.com/news/3258635-bmo-spots-value-in-fortinet-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258635-bmo-spots-value-in-fortinet-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258633\" data-ts=\"1492775446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258633-valeant-prices-psoriasis-med-siliq-3500-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant prices psoriasis med SILIQ at $3,500/month</a></h4><ul><li>Employing its pricing-by-committee approach to setting drug prices, Valeant Pharmaceutics (VRX) <a href=\"https://seekingalpha.com/pr/16806179-valeants-patient-access-pricing-committee-announces-pricing-siliq-brodalumab-lowest-priced\" target=\"_blank\">announces </a>that the list price for injectable plaque psoriasis medication SILIQ (brodalumab) will be $3,500 per month. The company says it is the lowest price on the market for an injectable biologic to treat the skin condition. U.S. commercial launch will commence in H2.</li><li>Valeant established its Patient Access and Pricing Committee a year ago amidst criticism over its aggressive price hikes.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket after several sell-side shops cut price targets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258633\" data-linked=\"Valeant prices psoriasis med SILIQ at $3,500/month\" data-tweet=\"$BHC - Valeant prices psoriasis med SILIQ at $3,500/month https://seekingalpha.com/news/3258633-valeant-prices-psoriasis-med-siliq-3500-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3258633-valeant-prices-psoriasis-med-siliq-3500-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>234&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258629\" data-ts=\"1492775002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPT\" target=\"_blank\">GPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258629-gramercy-property-trustminus-2_5-after-capital-raise-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gramercy Property Trust -2.5% after capital raise, earnings miss</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16806042-gramercy-property-trust-announces-pricing-public-offering-9000-000-common-shares\" target=\"_blank\">company sold 9M shares</a> at $27.60 each for estimated net proceeds of $238.1M. The underwriters have an option to buy another 1.35M shares at that price.</li><li>In preliminary numbers <a href=\"https://seekingalpha.com/news/3258460-capital-raise-gramercy-property-trust-q1-guidance-light\" target=\"_blank\">released last night</a>, Gramercy (NYSE:<a href='https://seekingalpha.com/symbol/GPT' title='Gramercy Property Trust, Inc.'>GPT</a>) expects core FFO of $0.50-$0.51 per share in Q1 vs. estimates for $0.53.</li><li>Shares&nbsp;<font color='red'>-2.45%</font>&nbsp;premarket to $27.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258629\" data-linked=\"Gramercy Property Trust -2.5% after capital raise, earnings miss\" data-tweet=\"$GPT - Gramercy Property Trust -2.5% after capital raise, earnings miss https://seekingalpha.com/news/3258629-gramercy-property-trustminus-2_5-after-capital-raise-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3258629-gramercy-property-trustminus-2_5-after-capital-raise-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258624\" data-ts=\"1492774526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258624-bmo-capital-sees-mcdonalds-rally-extending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO Capital sees McDonald&#39;s rally extending</a></h4><ul>     <li>BMO Capital initiates coverage on McDonald's (NYSE:<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>) with a Buy rating.</li>     <li>The investment firm begins coverage on the restaurant operator with a price target of $153. The <a href=\"https://www.marketbeat.com/stocks/NYSE/MCD/\" target=\"_blank\">consensus price target</a> on McDonald's from Wall Street firms is $130.30.</li>     <li>Shares of McDonald's are up <font color='green'>0.53%</font> premarket to $133.98 vs. a 52-week trading range of $110.33 to $133.44 (set yesterday)</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3258624\" data-linked=\"BMO Capital sees McDonald&#39;s rally extending\" data-tweet=\"$MCD - BMO Capital sees McDonald&#39;s rally extending https://seekingalpha.com/news/3258624-bmo-capital-sees-mcdonalds-rally-extending?source=tweet\" data-url=\"https://seekingalpha.com/news/3258624-bmo-capital-sees-mcdonalds-rally-extending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258622\" data-ts=\"1492774431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HON\" target=\"_blank\">HON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258622-honeywellplus-2_1-raising-guidance-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Honeywell +2.1% raising guidance range</a></h4><ul><li>Q1 adjusted EPS of $1.66 up 11% Y/Y, and topping estimates by $0.04.</li><li>Organic sales growth by segment in Q1: Aerospace flat; Home and Building +3%; Performance Materials +5%; Safety and Productivity +3%.</li><li>\"Honeywell reported a strong start to 2017, with over 2% organic sales growth, 70 bps of segment margin expansion, and free cash flow of nearly $800M that was more than six times greater than 2016,\" CEO Darius Adamczyk declared. \"As a result of our performance, we are raising the low end of our full-year guidance by $0.05. We now anticipate that 2017 earnings per share will be $6.90 to $7.10, up 7%-10%, excluding divestitures, any pension mark-to-market adjustments, and 2016 debt refinancing charges.</li><li><a href=\"https://event.webcasts.com/starthere.jsp?ei=1141236\" target=\"_blank\">Conference call</a> at 9:30 a.m. ET.</li><li><a href='https://seekingalpha.com/symbol/HON' title='Honeywell International, Inc.'>HON</a> <font color='green'>+2.1%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3258595-honeywell-beats-0_09-beats-revenue\" target=\"_blank\">Q1 results </a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258622\" data-linked=\"Honeywell +2.1% raising guidance range\" data-tweet=\"$HON - Honeywell +2.1% raising guidance range https://seekingalpha.com/news/3258622-honeywellplus-2_1-raising-guidance-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3258622-honeywellplus-2_1-raising-guidance-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258618\" data-ts=\"1492774273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOO\" target=\"_blank\">SHOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258618-on-steve-maddens-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Steve Madden&#39;s Q1</a></h4><ul>     <li>Steve Madden (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOO' title='Steven Madden, Ltd.'>SHOO</a>) reports same-store retail sales fell 6% in <a href=\"https://seekingalpha.com/pr/16806127-steve-madden-announces-first-quarter-2017-results\" target=\"_blank\">Q1</a>.</li>     <li>Wholesale net sales increased 13.6% to $313.3M</li>     <li>Retail gross margin up 250 bps to 58.7% due to a lower level of promotional activity.</li>     <li>Gross margin in the wholesale business grew 160 bps to 32.8% driven by an increase in the wholesale footwear segment.</li>     <li>Adjusted gross margin rate improved 130 bps to 36.6%.</li>     <li>Operating expenses as a percentage of sales down 10 bps to 26.8%.</li>     <li>Adjusted operating margin rate expanded 170 bps to 10.8%.</li>     <li><b>FY2017 Guidance</b>: Net sales: +8% to +10%; GAAP EPS: $1.97 to $2.03; Adjusted EPS: $2.12 to $2.18.</li>     <li>SHOO&nbsp;<font color='red'>-0.54%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258618\" data-linked=\"More on Steve Madden&#39;s Q1\" data-tweet=\"$SHOO - More on Steve Madden&#39;s Q1 https://seekingalpha.com/news/3258618-on-steve-maddens-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258618-on-steve-maddens-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258599\" data-ts=\"1492771687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBC\" target=\"_blank\">WBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258599-on-wabco-holdings-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on WABCO Holdings&#39; Q1</a></h4><ul>     <li>WABCO Holdings (NYSE:<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a>)&nbsp;reports sales rose 11% in local currencies in <a href=\"https://seekingalpha.com/pr/16806119-wabco-reports-q1-2017-results-continues-solidly-outperform-global-commercial-vehicle-market\" target=\"_blank\">Q1</a>.</li>     <li>Adjusted gross margin rate flat Y/Y at 31.7%.</li>     <li>SG&amp;A expense rate improved 20 bps to 12.3%.</li>     <li>Adjusted operating margin rate up 20 bps to 14.9%.</li>     <li><b>FY2017 Guidance</b>: Sales: $2.85B to $2.99B (+4% to +9% in local currencies); Adjusted operating margin rate: 14.7% to 15.1%; GAAP operating margin rate: 13.9% to 14.3%; Adjusted net income: $297.5M to $324.3M; GAAP net income: $291.5M to $318.3M; Adjusted EPS: $5.55 to $6.05; Diluted EPS: $5.44 to $5.94; Diluted shares&nbsp;outstanding: ~54M</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258599\" data-linked=\"More on WABCO Holdings&#39; Q1\" data-tweet=\"$WBC - More on WABCO Holdings&#39; Q1 https://seekingalpha.com/news/3258599-on-wabco-holdings-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258599-on-wabco-holdings-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258598\" data-ts=\"1492771629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258598-apricus-prices-equity-offering-1_40-unit-shares-off-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus prices equity offering at $1.40/unit; shares off 2% premarket</a></h4><ul><li>Thinly traded nano cap Apricus Biosciences (APRI) slips&nbsp;<font color='red'>2%</font>&nbsp;premarket on average volume in response to the <a href=\"https://seekingalpha.com/pr/16806103-apricus-biosciences-announces-pricing-7_0-million-public-offering\" target=\"_blank\">pricing </a>of its public offering of 5.03M units at $1.40 per unit.</li><li>Each unit consists of one share of common stock and one five-year warrant to purchase 0.75 of a share of common at $1.55. The warrants become exercisable only after the company receives shareholder approval to increase the number of authorized shares to 30M.</li><li>Net proceeds will fund the re-submission of the Vitaros NDA, working capital and general corporate purposes.</li><li>Yesterday's close was $1.37.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258598\" data-linked=\"Apricus prices equity offering at $1.40/unit; shares off 2% premarket\" data-tweet=\"$SEEL - Apricus prices equity offering at $1.40/unit; shares off 2% premarket https://seekingalpha.com/news/3258598-apricus-prices-equity-offering-1_40-unit-shares-off-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258598-apricus-prices-equity-offering-1_40-unit-shares-off-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":48,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}